EVMN

EVOMMUNE INC

• TipRanks·05/15 11:59

  Oppenheimer Sticks to Its Buy Rating for Evommune, Inc. (EVMN)

• TipRanks·05/15 09:15

  Matt Phipps Reiterates Buy on Evommune as EVO301 Data Strengthen IL‑18 Blockade Thesis and Support Blockbuster Potential

• TipRanks·05/14 01:50

  Analysts’ Top Healthcare Picks: Allogene Therapeutics (ALLO), Evommune, Inc. (EVMN)

• Dow Jones·05/11 17:21

  Evommune Is Maintained at Overweight by Morgan Stanley

• Benzinga·05/11 17:11

  Morgan Stanley Maintains Overweight on Evommune, Raises Price Target to $55

• Simply Wall St·05/09 01:30

  Evommune (EVMN) Earnings Decline Versus 85.7% Revenue Growth Tests Bullish Narratives

• TipRanks·05/08 12:45

  Evommune, Inc. (EVMN) Gets a Buy from RBC Capital

• Seeking Alpha·05/08 10:40

  Evommune, Inc. GAAP EPS of -$0.64

• TipRanks·05/08 00:36

  Evommune Earns Buy Rating on Late-Stage Pipeline Progress and Multiple Near-Term Clinical Catalysts

• TipRanks·05/07 20:48

  Evommune Highlights Q1 Results and Advancing Inflammation Pipeline

• TipRanks·04/30 20:39

  Evommune initiated with a Buy at Stifel

• TipRanks·04/30 19:40

  Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM), Evommune, Inc. (EVMN) and Alnylam Pharma (ALNY)

• TipRanks·04/25 16:30

  Evommune’s EVO756 Phase 2b Trial: An Emerging Catalyst in Atopic Dermatitis

• TipRanks·04/24 12:01

  Analysts Offer Insights on Healthcare Companies: Evommune, Inc. (EVMN) and Edwards Lifesciences (EW)

• TipRanks·04/23 12:38

  Six new option listings on April 23rd